This finding highlights the neuroprotective activity of PDG, which decreases neuroinflammation by modulating the TLR4/NF-κB pathway, thus reducing cognitive dysfunction in AD mice, suggesting that PDG is a potential drug for AD treatment. Here, TLR4 is linked to Alzheimer disease.